Advertisement
Trending - Altmetric
-
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
-
Osimertinib and palbociclib in an EGFR-mutated NSCLC with primary CDK4 amplification after progression under osimertinib
-
Prediction of TKI response in EGFR-mutant lung cancer patients-derived organoids using malignant pleural effusion
-
Redirecting NK cells to the lymph nodes to augment their lymphoma-targeting capacity